U.S. – Page 4 – Talk Bio

Novo Nordisk Invests $4.1 Billion in New US Manufacturing Site, Abandoning Irish Plans

1 year ago talkbio0Tagged Clayton, fill-finish facility, Irish, Irish (ethnic group), manufacturing site, Nordisk, North Carolina, Obesity, U.S.

Novo Nordisk, US manufacturing site, obesity drugs, fill-finish facility, Clayton, NC, Irish build

Amber Therapeutics Raises $100M for Closed-Loop Neuromodulation Implant for Urinary Incontinence

1 year ago talkbio0Tagged amber, closed-loop implant, Neurostimulation/modulation, Pelvis, regulatory approval, Structure of pudendal nerve, U.S., United States, Urinary Incontinence

Amber Therapeutics, urinary incontinence, neuromodulation, closed-loop implant, funding, series A round, pelvic pudendal nerve, mixed incontinence, U.S. regulatory approval.

CSL Seqirus Secures Fourth US Award to Enhance Bird Flu Vaccine Stockpile

1 year ago talkbio0Tagged Aves, BARDA, bird flu vaccine, CSHL1 gene, Government, Influenza in Birds, pandemic preparedness, public health protection, Seqirus, U.S., Vaccines

CSL Seqirus, bird flu vaccine, US government award, BARDA, pandemic preparedness, avian influenza, H5N1, vaccine stockpile, public health protection

Shimadzu Corporation Expands US Presence with Three New R&D Centers for Pharmaceutical Growth

1 year ago talkbio0Tagged business growth, Central, Corporation, Drug Industry, expansion, innovation, Shimadzu, Technology, U.S.

Shimadzu Corporation, R&D centers, US expansion, pharmaceutical industry, business growth, innovation, technology.

Novartis Reevaluates Chinese Contractor Ties Amidst US Biosecurity Concerns

1 year ago talkbio0Tagged Biosecurity, CFO, Chinese contractors, Novartis, Relationships, U.S.

Novartis, Chinese contractors, US biosecurity, CFO, review, relationships, crackdown